Irinotecan as first-line chemotherapy in patients with advanced hepatocellular carcinoma: A multicenter phase II study with dose adjustment according to baseline serum bilirubin level-Reference-Cited by-同舟云学术

Irinotecan as first-line chemotherapy in patients with advanced hepatocellular carcinoma: A multicenter phase II study with dose adjustment according to baseline serum bilirubin level

Published:2006-03 Issue:4 Volume:42 Page:456-459
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Boige Valérie,Taïeb Julien,Hebbar Mohamed,Malka David,Debaere Thierry,Hannoun Laurent,Magherini Emmanuelle,Mignard Dominique,Poynard Thierry,Ducreux Michel

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference15 articles.

1. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference, European Association for the Study of the Liver;Bruix;J Hepatol,2001

2. Chemoembolization for hepatocellular carcinoma;Bruix;Gastroenterology,2004

3. Systemic therapy for advanced hepatocellular carcinoma: a review;Nowak;Eur J Cancer,2004

4. Selective induction of apoptosis in Hep 3B cells by topoisomerase I inhibitors: evidence for a protease-dependent pathway that does not activate cysteine protease P32;Adjei;J Clin Invest,1996

5. Induction of senescent cell-derived inhibitor of DNA synthesis gene (SDI1), in hepatoma (HepG2) cells arrested in the G2-phase of the cycle by 9-nitrocamptothecin;Khaoustov;Lab Invest,1995

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unresectable Hepatocellular Carcinoma: A Review of New Advances with Focus on Targeted Therapy and Immunotherapy;Livers;2023-03-13

2. Topoisomerase I Inhibition Radiosensitizing Hepatocellular Carcinoma by RNF144A-mediated DNA-PKcs Ubiquitination and Natural Killer Cell Cytotoxicity;Journal of Clinical and Translational Hepatology;2023-01-04

3. Role of 5-methylcytosine in determining the prognosis, tumor microenvironment, and applicability of precision medicine in patients with hepatocellular carcinoma;Frontiers in Genetics;2022-09-16

4. Systemic Therapy for Hepatocellular Carcinoma: Current Updates and Outlook;Journal of Hepatocellular Carcinoma;2022-03

5. Correlation between Immunohistochemical Markers in Hepatocellular Carcinoma Cells and In Vitro High-Throughput Drug Sensitivity Screening;Canadian Journal of Gastroenterology and Hepatology;2022-01-25